Free Trial
NYSEAMERICAN:VTAK

Catheter Precision Q1 2026 Earnings Report

Catheter Precision logo
$0.15 +0.00 (+0.66%)
Closing price 10/2/2026 07:44 PM Eastern
Extended Trading
$0.15 0.00 (0.00%)
As of 10/2/2026 07:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Catheter Precision EPS Results

Actual EPS
-$13.90
Consensus EPS
-$209.00
Beat/Miss
Beat by +$195.10
One Year Ago EPS
N/A

Catheter Precision Revenue Results

Actual Revenue
$0.43 million
Expected Revenue
$1.60 million
Beat/Miss
Missed by -$1.17 million
YoY Revenue Growth
N/A

Catheter Precision Announcement Details

Quarter
Q1 2026
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Catheter Precision's next earnings date is estimated for Thursday, November 12, 2026, based on past reporting schedules.

Conference Call Resources

Catheter Precision Earnings Headlines

Flyte Aviation Rebrands and Executes Reverse Stock Split
Flyte Aviation Launches Under NYSE American Ticker “VJET”
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required. Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away.tc pixel
Catheter Precision, Inc. will Change its Ticker to VJET from VTAK
See More Catheter Precision Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Catheter Precision? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Catheter Precision and other key companies, straight to your email.

About Catheter Precision

Catheter Precision (NYSEAMERICAN:VTAK) is a medical device company focused on developing technologies for electrophysiology procedures used to diagnose and treat cardiac arrhythmias. Its products are designed to support physicians during catheter-based cardiac procedures, particularly those involving ventricular arrhythmias.

The company’s portfolio includes the VIVO system, a noninvasive cardiac mapping platform intended to help physicians identify the origin of ventricular arrhythmias and plan catheter ablation procedures. Catheter Precision also markets LockeT, a device designed to help secure introducer sheaths and catheters during electrophysiology and other cardiovascular procedures.

Catheter Precision was formerly known as Ra Medical Systems and adopted its current name as it shifted its focus toward electrophysiology products. The company is based in Fort Mill, South Carolina, and serves the medical device and healthcare markets through commercialization and development of its cardiac procedure technologies.

View Catheter Precision Profile